NFE2L2 and cancer: To eliminate elevated ROS in cancer cells, several antioxidant mechanisms, such as the Kelch-like ECH-associated protein 1–nuclear factor erythroid 2-related factor 2 (KEAP1–NRF2) pathway, are activated [17].